Related by context. All words. (Click for frequent words.) 70 Corlux 65 Davanat 65 MyVax 65 Allovectin 7 65 PrevOnco 64 vinflunine 64 Tocosol Paclitaxel 64 midstage clinical 64 RSR# 64 Vertex hepatitis C 63 Onco TCS 63 Provenge prostate cancer 63 PF # [002] 63 Velcade bortezomib 63 Omapro 63 Canvaxin 63 PTK ZK 63 Zybrestat 63 ixabepilone 63 Ixempra 63 Orathecin 62 Dendreon Provenge 62 midstage clinical trial 62 refractory chronic lymphocytic 62 ImClone Erbitux 62 Onconase 62 Nexavar ® 62 Fodosine 62 Campath ® 62 ALN PCS 62 compound INCB# 62 Insegia 62 Personalized Immunotherapy 62 Zalbin 62 drug Treanda 62 PLK1 SNALP 62 proteasome inhibitor 62 OncoVex 62 Troxatyl 62 SinuNase ™ 62 OvaRex 62 KRYSTEXXA TM pegloticase 62 Vectibix panitumumab 61 Asentar 61 virus HCV protease inhibitor 61 Tykerb lapatinib 61 Daclizumab 61 lumiliximab 61 drug figitumumab 61 Allovectin 7 ® 61 alvespimycin 61 apaziquone 61 Phase IIb clinical trials 61 ponatinib 61 peginesatide 61 Alimta pemetrexed 61 trastuzumab DM1 61 Theratope 61 Nabi HB Intravenous 61 brentuximab vedotin SGN 61 Arzerra 61 LymphoStat B belimumab 61 Trastuzumab DM1 61 PTK# 61 Amgen Vectibix 61 oral ridaforolimus 61 Biologic License Application BLA 61 Chemokine Therapeutics 60 Nexavar sorafenib 60 ridaforolimus 60 LymphoStat B TM 60 ospemifene 60 gepirone ER 60 Symbicort asthma 60 Diamyd ® 60 Valtropin 60 ASONEP 60 RANK Ligand inhibitor 60 dacetuzumab 60 supplemental biologics 60 Adventrx 60 acyclovir Lauriad R 60 Urocidin 60 Specifid 60 Campath alemtuzumab 60 VitiGam 60 FOLOTYN ® 60 OMAPRO ™ 60 IMC #B 60 Antegren 60 midstage studies 60 bardoxolone 60 blood clot preventer 60 blood thinner prasugrel 60 Pirfenidone 60 commercialize deforolimus 60 JAK inhibitor 60 Muraglitazar 60 relapsed leukemia 60 Sprycel 60 Gattex 60 Uplyso 60 Crizotinib 60 BLP# Liposome Vaccine 60 Reverset 60 midstage clinical trials 60 Aflibercept 59 PrevOnco ™ 59 severe hypercholesterolemia 59 Kalbitor 59 Evoltra ® 59 OvaRex ® MAb 59 ATPace TM 59 apricitabine ATC 59 Evoltra 59 MAGE A3 ASCI 59 drug GAP #B# 59 Premarket Approval Application 59 elotuzumab 59 phase IIb clinical 59 Amrubicin 59 Advexin 59 Oxigene 59 midstage study 59 Rapinyl 59 Salmedix 59 Somatuline Depot 59 Uvidem 59 reslizumab 59 Oglemilast 59 Bonefos 59 vemurafenib 59 L BLP# 59 ISO Vorin TM 59 Folotyn 59 Albugon 59 successfully commercialize Iluvien 59 Genentech Rituxan 59 therapeutic monoclonal antibody 59 cetuximab Erbitux 59 Archexin 59 CDP# 59 Novartis Afinitor 59 Rituxan rituximab 59 Temsirolimus 59 ZALBIN 59 DPX Survivac 59 Roche Chugai 59 MOZOBIL 59 TOCOSOL Camptothecin 59 Panzem 59 ocrelizumab 59 investigational oral hepatitis C 59 StemEx R 59 Celgene Revlimid 59 Genentech Roche 59 lintuzumab SGN 59 Onrigin 59 Fx #A 59 Mepact 59 Panzem R NCD 59 midstage trials 59 NV1FGF 59 NeuVax 59 Neuvenge 59 lorvotuzumab mertansine 59 Soliris TM eculizumab 59 Ocrelizumab 59 Xyotax 59 Iluvien ® 58 Bayer Nexavar 58 Arzerra ofatumumab 58 Treanda 58 MyVax ® 58 UCB Cimzia 58 Jevtana 58 Simponi golimumab 58 Pirespa 58 Zactima 58 Evoltra R 58 BrachySil 58 including eniluracil ADH 58 Zensana 58 Proxinium TM 58 Panzem R 58 OncoVEX 58 IL# PE#QQR 58 Tocosol 58 ONSOLIS TM 58 Mozobil 58 R sorafenib tablets 58 huC# DM4 58 commercialize toremifene 58 Zenapax 58 Erbitux cetuximab 58 QNEXA ® 58 Oporia 58 mipomersen 58 IV APAP 58 JZP 6 58 Hedgehog antagonist 58 ABX EGF 58 Annamycin 58 Flutiform 58 CAMPATH 58 Herceptin trastuzumab 58 Camvia 58 MyVax personalized immunotherapy 58 rolapitant 58 non nucleoside inhibitor 58 OvaRex R 58 MyVax R 58 personalized immunotherapy 58 Erbitux ImClone 58 experimental lupus 58 Ceplene TM 58 Eliquis 58 ALN VSP Phase 58 TACI Ig 58 vosaroxin 58 novel therapeutic antibodies 58 pivotal bioequivalence 58 Ziopharm 58 rALLy trial 58 Pulminiq 58 ANTEGREN 58 RhuDex ® 58 Aveo Pharmaceuticals 58 KNS # 58 Trisenox 58 Preos 58 phase IIb trial 58 AnGes MG 58 Civacir 58 NASDAQ OSIR 58 Phenoptin 58 BAY #-# 58 IMA# 58 Kynapid 58 StaphVAX 58 cediranib 58 XL# XL# XL# XL# 58 Marketing Authorisation Application 58 Tyzeka Sebivo 58 Xcytrin R 58 PANVAC VF 58 initiate Phase IIb 58 lintuzumab 58 systemic ALCL 58 deforolimus 58 Brentuximab Vedotin SGN 58 Omnitarg 58 XL# XL# 58 Millennium Velcade 58 tafamidis 58 Onyx Pharmaceuticals Inc 58 UPLYSO 58 IND Investigational New 58 maribavir 58 Levoleucovorin 58 Zolinza 58 Gleevec imatinib mesylate 58 OSI Tarceva 58 platforms GVAX 58 LAF# 57 PDX pralatrexate 57 vaccines oncolytic virus 57 TransMID 57 Bayer Onyx 57 Telcyta 57 Initiates Phase III 57 Fusilev 57 Memryte 57 Gleevec Glivec 57 Zelrix 57 inhaled AAT 57 thalidomide Thalomid 57 Genentech Herceptin 57 sNDA filing 57 Fortigel 57 ATG Fresenius S 57 Vibativ 57 Xcellerated T Cells 57 ruxolitinib 57 CVac 57 Adamis Pharmaceuticals 57 Arcalyst 57 Wellstat 57 glucokinase activator 57 YONDELIS 57 BRAF inhibitor 57 volociximab 57 TBC# 57 Taiho Pharmaceutical 57 rALLy clinical trial 57 initiated Phase 1b 57 Cladribine 57 IV acetaminophen 57 cinacalcet HCl 57 experimental hepatitis C 57 BEXXAR 57 Unit Dose Budesonide 57 rhThrombin 57 FlutiformTM 57 ATL# [001] 57 AP# [003] 57 Nanobody R 57 Prestara 57 immunotherapeutic vaccine 57 Rezonic 57 ZEFTERA TM Zevtera TM 57 Nasdaq SGEN 57 Troxatyl TM 57 BioNumerik 57 SinuNase TM 57 HuMax TAC 57 Recentin 57 progressive metastatic prostate 57 clinical trials SGN 57 RELOVAIR ™ 57 Biologic License Application 57 Solzira 57 DCVax R 57 Benlysta belimumab 57 tolevamer 57 fostamatinib 57 Nuvion 57 FavId 57 SuperAntibody 57 Galida 57 regorafenib 57 NASDAQ PCYC 57 AstraZeneca Iressa 57 generation purine nucleoside 57 TREANDA 57 HepeX B 57 Onglyza saxagliptin 57 Generx ™ 57 registrational 57 Surfaxin LS 57 intravenous acetaminophen 57 compound KOS 57 EGS# 57 solanezumab 57 Entocort 57 Omacetaxine 57 Genasense ® 57 Votrient 57 carfilzomib 57 SciClone Pharmaceuticals Inc. 57 BiovaxID ® 57 mertansine 57 Files Investigational 57 motesanib 57 Pegloticase 57 Seattle Genetics SGEN 57 E2F Decoy 57 Cutanea Life Sciences 57 REOLYSIN ® 57 ToGA 57 gefitinib Iressa 57 GSK# [002] 57 Revlimid lenalidomide 57 Nebido 57 pralatrexate 57 ADVEXIN p# therapy 57 dirucotide 57 TRANSDUR Sufentanil 57 tremelimumab 57 Avastin Tarceva 57 Aplidin 57 MK #B 57 Evoltra TM 57 Gleevec imatinib 57 ofatumumab HuMax CD# 56 SUCCEED trial 56 rThrombin 56 Ridaforolimus 56 Pfizer Sutent 56 Phase III TRIST 56 NASDAQ INFI 56 OPAXIO 56 Accentia Biopharmaceuticals 56 tiapamil 56 Hematide ™ peginesatide 56 Allovectin 7 R 56 GA GCB 56 ONCONASE R 56 BEMA TM Fentanyl 56 sorafenib tablets 56 T Pred 56 liprotamase 56 Cetrorelix 56 Acapodene 56 Roche Holding AG RHHBY 56 LONDON AFX GlaxoSmithKline PLC 56 Genentech Avastin 56 Curaxis 56 Junovan 56 Somatuline Autogel 56 Kosan dependence 56 TOCOSOL Paclitaxel 56 phase IIa clinical 56 Celgene Thalomid 56 Ceflatonin 56 CombinatoRx Incorporated 56 molecular imaging radiopharmaceutical 56 IAP inhibitors 56 Pixuvri 56 FoldRx 56 Virulizin 56 Aurexis 56 Telavancin 56 BEMA Fentanyl 56 Genz # 56 anastrozole Arimidex 56 Pfizer maraviroc 56 etanercept Enbrel 56 Æterna Zentaris 56 follicular Non Hodgkin 56 CIMZIA r 56 Satraplatin 56 Krystexxa 56 refractory Hodgkin lymphoma 56 Immunogen 56 MethyPatch 56 metastatic carcinoid 56 EOquin TM 56 orBec 56 sirtuin modulators 56 Omigard 56 Therion Biologics 56 Kiacta 56 Zytiga 56 Cinquil 56 NYSE Amex PTN 56 registrational trial 56 Factor Xa inhibitor 56 multiple myeloma MM 56 Cloretazine 56 Fablyn 56 LEVADEX ™ 56 cancer immunotherapies 56 neratinib 56 Vion Pharmaceuticals 56 Sebivo 56 dermatology biopharmaceutical 56 Amigal 56 EndoTAG TM -1 56 Febuxostat 56 SinuNase 56 Albuferon albinterferon alfa 2b 56 Vitaxin 56 Exenatide LAR 56 initiate Phase Ib 56 galiximab 56 HuMax CD4 56 Etubics 56 Xcytrin 56 Vandetanib 56 Galvus vildagliptin 56 SCIB1 56 aflibercept 56 Zarnestra 56 gaboxadol 56 JCR Pharmaceuticals 56 Certriad 56 multi kinase inhibitor 56 abiraterone 56 Aryplase 56 erlotinib Tarceva 56 hoFH 56 TKPHF 56 Inc. Nasdaq SGXP 56 Ventrus 56 Diamyd R 56 Alemtuzumab 56 anti CD3 monoclonal 56 Velac 56 BLP# 56 Santhera 56 Stedesa 56 KRN# 56 NASDAQ OMER 56 Iressa gefitinib 56 LibiGel NDA 56 Mipomersen 56 SEBIVO 56 investigational hepatitis C 56 Cerovive 56 Zadaxin 56 ILUVIEN ® 56 JOULFERON 56 AEG# 56 Dacogen injection 56 Medivation Inc 56 Cabazitaxel 56 commercialize MDV# 56 EGRIFTA TM 56 IV Busulfex 56 Vertex telaprevir 56 enzastaurin 56 eritoran 56 oral methylnaltrexone 56 Marketing Authorization Application 56 oral prodrug 56 Omigard TM 56 Nanobody 56 Myrexis 56 Raf kinase inhibitor 56 Syncria 56 Trubion Pharmaceuticals TRBN 56 diabetes irritable bowel 56 Renvela 56 daclizumab 56 Zensana TM 56 Marketing Authorisation Application MAA 55 Asentar TM 55 VentiRx 55 Elan Tysabri 55 Asubio 55 Cellegesic 55 Yervoy 55 PNP inhibitor 55 Junovan TM 55 Affinitak 55 BENLYSTA ® 55 Novartis NVS Snapshot Report 55 AVASTIN 55 Campath 55 FOLOTYN 55 Hodgkin lymphoma HL 55 Amgen Neulasta ® 55 Provenge sipuleucel T 55 aerosolized AAT 55 ZURICH AFX Novartis AG 55 budesonide MMX ® 55 REMOXY R 55 Rotarix ® 55 Dacogen decitabine 55 TroVax 55 omacetaxine 55 Ortho Biotech Oncology 55 Zyflo 55 Phase Ib study 55 Phase Ib II 55 Approvable letter 55 TolerRx 55 metastatic renal cell 55 Cimzia TM 55 Initiate Clinical Trial 55 Biologics License Application BLA 55 MAA submission 55 immunological diseases 55 BENLYSTA 55 rolofylline 55 Iloperidone 55 otelixizumab 55 BCR ABL inhibitors 55 Firazyr 55 Aryx 55 glufosfamide 55 Arranon 55 Urocidin TM 55 Luveniq 55 investigational monoclonal antibody 55 Roche Xeloda 55 MAb therapy 55 dexanabinol 55 Alnylam Nasdaq ALNY 55 ZOLINZA 55 Emezine 55 atacicept 55 nucleotide analogue 55 Saforis 55 metastatic hormone refractory 55 Temodar ® 55 Cleviprex TM clevidipine 55 PCA3 test 55 Doribax 55 MOVIPREP R 55 Zenvia TM 55 Icatibant 55 Cougar Biotechnology Inc. 55 CoTherix 55 Sunesis Pharmaceuticals 55 forodesine hydrochloride 55 Kamada AAT 55 bazedoxifene 55 Beyond Advair 55 refractory APL 55 Vivus Inc 55 Curagen 55 Abiraterone acetate 55 Tysabri natalizumab 55 Vertex Pharma 55 Oncotype DX colon cancer 55 3 registrational trial 55 Safinamide 55 Nasdaq OPTR 55 Taxotere docetaxel 55 ENRICH trial 55 Ceflatonin R 55 HuLuc# 55 Vidaza azacitidine 55 DCVax 55 MabThera Rituxan 55 VivaGel ™ 55 dirucotide MBP# 55 Romidepsin 55 Pradefovir 55 PDE4 inhibitor 55 methylnaltrexone 55 MEPACT 55 Balaglitazone 55 Inc. NASDAQ SGEN 55 ITAX 55 Dalbavancin 55 LEUKINE 55 Nycomed GmbH 55 BLA filing 55 Myrexis Inc. 55 EOquin 55 Dynepo 55 Clofarabine 55 Tolamba 55 eprodisate KIACTA TM 55 Joulferon 55 StaphVAX R 55 Nexavar tablets 55 EFAPROXYN 55 PHX# 55 hepatitis B vaccine Heplisav 55 Quinamed 55 PRECISE trial 55 drug conjugate 55 Completes Patient Enrollment 55 Zenvia ™ 55 ZEVALIN ® 55 satraplatin 55 Collategene 55 Argatroban 55 Bellicum Pharmaceuticals Inc. 55 pill Galvus 55 pertuzumab 55 Sutent sunitinib 55 octreotide implant 55 Dacogen 55 Onyx Pharmaceuticals 55 Desmoteplase 55 faropenem medoxomil 55 Levadex 55 EndoTAGTM 1 55 Daniel Junius 55 teplizumab 55 Lung Rx 55 VitiGam TM 55 PEG SN# 55 cabozantinib 55 Inc. Nasdaq VVUS 55 docetaxel Taxotere R 55 Alnara 55 MNTX 55 Xinlay 55 Targretin capsules 55 Paraplatin 55 Zymafos 55 Holding AG ROG.VX 55 BRIM3 55 Roche Herceptin 55 sumatriptan injection 55 Prosaptide 55 Acetavance 55 Celladon Corporation 55 STEDESA 55 Pancreate 55 VEGF Trap 55 Altus Pharmaceuticals 55 Vicriviroc 55 Dificid 55 aclidinium bromide 55 Roche Genentech 55 Hollings Renton 55 lapatinib Tykerb 55 Campto 55 MolecularMD 55 Nasdaq ACHN 55 AnGes 55 almorexant 55 aleglitazar 55 metastatic HRPC 55 SAR# [004] 55 MCSP respectively 55 Friedreich Ataxia FRDA 54 Zerenex 54 voclosporin 54 Trubion Pharmaceuticals 54 BioDelivery 54 Xenoport Inc. 54 GLP toxicology studies 54 NASDAQ MLNM 54 Preotact 54 Telatinib 54 Ereska 54 Tezampanel 54 Onyx Pharma 54 Alzhemed TM 54 Sulonex 54 Marqibo 54 Orapred ODT 54 INDs 54 Phase #/#a trial 54 oral taxane 54 dalbavancin 54 Somatuline R Autogel R 54 CONBRIZA 54 Onalta ™ 54 YONDELIS R 54 Initiates Phase II 54 Oracea TM 54 DEB# 54 vismodegib 54 Anturol ® 54 Joshua Boger Ph.D. 54 Roche OTC RHHBY 54 elacytarabine 54 Generx TM 54 Retacrit 54 Oasmia 54 ularitide 54 Neogenix 54 zanolimumab 54 Xeloda ® 54 Luveris 54 histamine dihydrochloride 54 DepoMed 54 Nasdaq SPPI 54 Lurasidone 54 eniluracil 54 Novartis Galvus 54 MGN# 54 hepatitis C viral infection 54 Peregrine Pharmaceuticals Inc. 54 rituximab Rituxan 54 Novantrone 54 ASA# 54 RIGScan CR 54 Clevudine 54 product platforms GVAX 54 NASDAQ CXSP announced 54 NVA# 54 ZACTIMA 54 LymphoStat B 54 Pegintron 54 Certican 54 ganetespib 54 brentuximab vedotin 54 StaphVax 54 Genasense ® oblimersen 54 Rhucin R 54 Antigenics 54 liposomal formulation 54 Telintra 54 Immunomedics 54 Vantas 54 Saphris 54 Alnylam RNAi 54 Tarsa Therapeutics 54 HuMax CD# 54 Biologics License Application 54 BLOOM DM 54 Aegerion Pharmaceuticals Inc. 54 Ambrisentan 54 immunotherapeutic agent 54 Phase III clinical 54 BLA submission 54 phase Ib 54 amrubicin 54 GlaxoSmithKline Tykerb 54 Onalta 54 axitinib 54 Zenyaku Kogyo 54 NASDAQ ABII 54 Oscient Pharmaceuticals Corp. 54 vilazodone 54 GATTEX TM 54 Avastin adjuvant 54 Abraxane 54 Tasigna nilotinib 54 POSIDUR TM ELADUR TM 54 Donald L. Drakeman 54 Metabasis Therapeutics 54 Enjuvia 54 sumatriptan DosePro 54 Optimer Pharmaceuticals Inc 54 TransVax 54 ThermoDox R 54 Phase IIb trials 54 Nasdaq IMGN 54 XL# anticancer compounds 54 pradefovir 54 nephropathic cystinosis 54 ZK EPO 54 Metabasis Therapeutics Inc. 54 Kissei Pharmaceutical 54 Oncogenex 54 initiate Phase 1b 54 Panitumumab 54 Lupuzor 54 Maraviroc 54 Telaprevir 54 Gliadel Wafer 54 Glaxo Tykerb 54 Sulonex TM 54 Oncoscience AG 54 Firdapse 54 Fibrin Pad 54 Afresa 54 ASG 5ME 54 Mersana 54 Eligard ® 54 James Manuso 54 midstage clinical testing 54 oxymorphone ER 54 methylnaltrexone bromide 54 histone deacetylase HDAC inhibitor 54 Ferumoxytol 54 Dynavax Technologies Corporation 54 Viramidine 54 NASDAQ ONXX 54 Avastin Herceptin 54 AmpliMed 54 miRNA therapeutics 54 pegylated interferon lambda 54 imatinib mesylate Gleevec 54 Syntonix Pharmaceuticals 54 Promacta 54 Trexima 54 Alogliptin 54 UltiMAb 54 optimal dosing regimens 54 Empatic TM 54 Epratuzumab 54 Schering Plough Corp SGP.N 54 Reolysin 54 Zemplar Capsules 54 phase IIa 54 CytoFab 54 prGCD 54 Peggy Pinkston 54 Ketotransdel 54 Alocrest 54 olaparib 54 Taxotere chemotherapy 54 ADVEXIN 54 LO LOESTRIN FE 54 crizotinib 54 fesoterodine 54 Cabilly patent 54 commercialize elagolix 54 overactive bladder AA# 54 Sonus Pharmaceuticals 54 nonsmall cell lung cancer 54 Cleveland Biolabs 54 panitumumab 54 subcutaneous formulation 54 rindopepimut 54 Plenaxis 54 phase IIb 54 non hodgkin lymphoma 54 CRD5 54 cardio renal 54 PREOS R 54 baminercept 54 Nipent R 54 MK #A [001] 54 Asenapine 54 terlipressin 54 forodesine 54 Frova ® 54 Amgen Inc AMGN.O 54 Voraxaze 54 Relistor 54 faropenem 54 ® decitabine 54 Nasdaq VRTX 54 Naproxcinod 54 CINTREDEKIN BESUDOTOX 54 Aztreonam 54 Clolar 54 hematological malignancy 54 Dacetuzumab 54 SNT MC# 54 Saxagliptin 54 Novartis Gleevec 54 Aegerion 54 Idenix Pharmaceuticals 54 Trovax 54 Nasdaq BIIB 54 Zyflo CR 54 KIACTA ™ 54 advanced metastatic prostate 54 Zingo TM 54 INCB# [002] 54 Akela Pharma 54 FDA approvable letter 54 fipamezole 54 CoFactor 54 PLX# 54 Panacos Pharmaceuticals 54 Romiplostim 54 relapsing remitting MS RRMS 54 squamous non 54 REMOXY NDA 54 PCA3 assay 54 HCV protease inhibitor 54 Flutiform TM 54 CRMD# 54 Spectrum Pharmaceuticals 54 exenatide LAR 54 Portola Pharmaceuticals 54 alemtuzumab Campath 54 MAXY VII 54 Pharmion Corporation 54 Inc. Nasdaq IMGN 54 Novartis AG Gleevec 54 novel oral anticoagulant 53 Increlex TM 53 LidoPAIN SP 53 Calixa Therapeutics 53 hepatitis C polymerase inhibitor 53 laninamivir 53 Paion 53 Trubion Pharmaceuticals Inc. 53 Olaparib 53 Submits Investigational 53 Tranzyme 53 Relovair 53 BNC# 53 Pfizer Exubera 53 regadenoson 53 relapsed multiple myeloma 53 Deferiprone 53 Submits Response 53 balsalazide tablet 53 Phase IIIb clinical 53 Bicifadine 53 Pralatrexate 53 Stimuvax R 53 Phase IIb III 53 investigational integrase inhibitor 53 Vertex Pharmaceuticals Inc 53 CeNeRx BioPharma 53 Hana Biosciences 53 Dr. McHutchison 53 sterile lidocaine patch 53 vinorelbine tartrate 53 ViaCyte 53 Ostabolin C TM 53 GlaxoSmithKline plc GSK 53 Spiegelmer ® 53 EDEMA3 53 Oral Calcitonin 53 OTCBB CVBT 53 Avila Therapeutics 53 Hepatocellular Carcinoma HCC 53 ELND# 53 Sprycel dasatinib 53 SUMAVEL 53 Pivotal Phase III 53 gastrointestinal stromal tumors 53 DepoBupivacaine TM 53 taribavirin 53 Vernakalant 53 Solasia 53 GEM #S 53 LibiGel ® 53 Quark Pharmaceuticals 53 Avastin bevacizumab 53 OVA1 TM 53 QNEXA 53 WILEX 53 Phase III Pivotal 53 vernakalant hydrochloride 53 immunosuppressant therapies 53 Liprotamase 53 gastrointestinal stromal tumors GIST 53 Galenea 53 figitumumab 53 Inc. Nasdaq MLNM 53 Advagraf 53 Replagal 53 OncoVEX GM CSF 53 TAXUS Element Stent System 53 Hybridon 53 Acadia Pharmaceuticals 53 fluoro sorafenib 53 alogliptin 53 KYNAPID